GTHIX
Price
$37.25
Change
-$0.35 (-0.93%)
Updated
Jun 10 closing price
Net Assets
1.16B
JFNIX
Price
$81.09
Change
-$1.14 (-1.39%)
Updated
Jun 10 closing price
Net Assets
5.4B
Interact to see
Advertisement

GTHIX vs JFNIX

Header iconGTHIX vs JFNIX Comparison
Open Charts GTHIX vs JFNIXBanner chart's image
GTHIX vs JFNIX Comparison Chart in %
View a ticker or compare two or three
VS
GTHIX vs. JFNIX commentary
Jun 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTHIX is a Buy and JFNIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 5.4B vs. GTHIX (1.16B). JFNIX pays higher dividends than GTHIX: JFNIX (0.45) vs GTHIX (0.00). GTHIX was incepted earlier than JFNIX: GTHIX (21 years) vs JFNIX (17 years). GTHIX (1.07) is less costly to investors than JFNIX (0.78). GTHIX is a more actively managed with annual turnover of: 59.00 vs. JFNIX (30.00). GTHIX has a lower initial minimum investment than JFNIX: GTHIX (1000) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : 21.78 vs. GTHIX (4.33). JFNIX return over 5 years is better than : 12.43 vs. GTHIX (-19.12).
GTHIXJFNIXGTHIX / JFNIX
Total Expense Ratio1.070.78137%
Annual Report Gross Expense Ratio1.070.78137%
Fund Existence21 years17 years-
Gain YTD-2.968-0.0863,441%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets1.16B5.4B21%
Annual Yield % from dividends0.000.45-
Returns for 1 year4.3321.7820%
Returns for 3 years7.8017.8644%
Returns for 5 years-19.1212.43-154%
Returns for 10 years8.1376.2211%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LGPS0.790.03
+4.53%
LogProstyle Inc
O62.110.86
+1.40%
Realty Income Corp
SMTI22.990.27
+1.19%
Sanara MedTech
HNGE62.06-0.72
-1.15%
Hinge Health Inc.
AKTS18.60-0.38
-2.00%
Aktis Oncology Inc